Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Nebraska
University of Nebraska
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
National Cancer Institute (NCI)